News Channels

09 Jul 2021 Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
09 Jul 2021 I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge mRNA and AI Technology Platforms
09 Jul 2021 Bacainn Therapeutics Presents at ECCO ‘21 Results from Phase 1 Study that Shows BT051, an Oral, Locally-Acting Inhibitor of Neutrophil Trafficking and Activity, Is Safe and Well-Tolerated in Healthy Adults
09 Jul 2021 bluebird bio Announces Positive Recommendation by PRAC Regarding Article 20 Safety Referral Review of ZYNTEGLO™ Gene Therapy for Transfusion-Dependent β-thalassemia and Marketing to Resume in EU
09 Jul 2021 Mirikizumab Up-Regulates Genes Associated with Mucosal Healing in Ulcerative Colitis for Up to One Year in Phase 2 Study
09 Jul 2021 Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)
09 Jul 2021 Akston Biosciences Announces Positive Phase I Data for Second-Generation COVID-19 Vaccine Candidate
09 Jul 2021 Verge Genomics Announces Three-Year Collaboration With Lilly to Discover and Develop Novel Treatments Using Its AI-Driven All-in-Human Platform
09 Jul 2021 F-star Therapeutics Enters into Exclusive Licensing Agreement with AstraZeneca for Novel STING Inhibitors
09 Jul 2021 FDA Approves Updated ADUHELM™ Prescribing Information to Emphasize Population Studied in Clinical Trials
09 Jul 2021 DESTINY-Gastric04 Head-to-Head Phase 3 Trial of ENHERTU(R) Initiated in Patients with HER2 Positive Advanced Gastric Cancer
08 Jul 2021 ASC Therapeutics Receives IND Clearance From the U.S. Food and Drug Administration for ASC618 Second-Generation Gene Therapy for Hemophilia A
08 Jul 2021 Bioasis Announces Positive Results From an Efficacy Study of xB3-IL-1RA in a Model of Multiple Sclerosis
08 Jul 2021 Treos Bio Enters into Clinical Collaboration to Evaluate its Polypeptide Cancer Immunotherapy PolyPEPI1018 in Combination with Roche’s PD-L1-Inhibitor
08 Jul 2021 Tezepelumab regulatory submission accepted and granted FDA Priority Review in the US for the treatment of patients with asthma
07 Jul 2021 Pathios Therapeutics Presents Preclinical In Vivo Proof of Concept Data for small molecule GPR65 inhibitor in human PDX cancer model
07 Jul 2021 Moderna Announces First Participant Dosed in Phase 1/2 Study of Its Quadrivalent Seasonal Flu mRNA Vaccine
07 Jul 2021 Valneva Awarded FDA Breakthrough Designation for its Single-Shot Chikungunya Vaccine Candidate
07 Jul 2021 Orgenesis Achieves Multiple Ranpirnase Development Milestones
07 Jul 2021 Eisbach Bio receives EUR 8 million government grant to progress COVID-19 antiviral through Phase I/II clinical development

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up